Director of Business Development

Company Description

Hit Gen Inc. (SSE: 688222.SH) is a global drug discovery research company headquartered in Chengdu, China, with subsidiaries in Cambridge, UK and Houston, USA. The company has established leading technology platforms for discovering and optimizing small molecules and nucleic acid-based drugs, with a strong focus on DNA-encoded library (DEL) technology. Hit Gen also leverages fragment-based and structure-based drug design (FBDD/SBDD), oligonucleotide-based therapeutics (OBT), and targeted protein degradation (TPD) technologies.

A DEL+AI+ automated DMTA (Design-Make-Test-Analyze) platform further accelerates preclinical candidate optimization. Through diverse collaboration models, Hit Gen works with hundreds of biopharmaceutical organizations worldwide and advances multiple programs from early discovery to clinical trial stages.

• Own and execute the sales and business development strategy for small molecule discovery services, including DEL, hit finding, and hit optimization.
• Generate and qualify new commercial leads through outbound prospecting, existing relationships, conferences, and partnering meetings.
• Lead the full sales cycle: initial outreach, scientific discussions, proposal development, pricing strategy, contract negotiation, and deal closure.
• Sell discovery programs covering DNA-encoded library screening, hit validation, medicinal chemistry, and hit-to-lead / hit optimization.
• Act as the primary commercial point of contact for clients, ensuring strong relationships and repeat business.
• Collaborate closely with internal discovery, chemistry, and project teams to scope programs that meet client goals while supporting revenue growth.
• Represent the company at industry conferences, partnering events, and scientific meetings.
• Maintain accurate forecasting, pipeline reporting, and CRM updates for leadership.
• Monitor competitive landscape and market trends to refine sales messaging and strategy.
• Help position the company’s other capabilities, including oligonucleotide synthesis for research and drug discovery, chemical synthesis, biochemical and cell based assays, animal studies to relevant partners.

• Minimum 5 years of experience in business development or scientific sales within biotech, pharma, CRO, or platform technology organizations.
• Strong working knowledge of small molecule drug discovery, including DNA-Encoded Libraries (DEL) and hit optimization workflows.
• Demonstrated experience selling complex, science-driven services or technologies.
• Familiarity with small molecule and other drug modalities and their discovery or optimization challenges.
• Proven ability to consistently close deals and meet or exceed revenue targets.
• Exceptional communication, presentation, and negotiation skills, with the ability to engage both scientific and executive stakeholders.
• Self-directed, results-oriented mindset with strong organizational skills.